These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1672986)

  • 21. Hepatitis C infection in BMT patients.
    Kolho E; Ruutu P; Ruutu T
    Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New-generation RIBA hepatitis C strip immunoblot assays.
    Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
    Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.
    Cassani F; Muratori L; Manotti P; Lenzi M; Fusconi M; Ballardini G; Selleri L; Volta U; Zauli D; Miniero R
    Gut; 1992 Sep; 33(9):1260-3. PubMed ID: 1330845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low cost anti-HCV screening of blood donors.
    Neill AG; Conradie JD
    Lancet; 1992 Oct; 340(8827):1096. PubMed ID: 1357481
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatitis C virus and serologic tests for detection of viral hepatitis C].
    Bode JC; Alscher DM
    Med Klin (Munich); 1992 Oct; 87(10):527-31, 549. PubMed ID: 1334216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative characterization of test systems in the diagnosis of viral hepatitis C].
    Bogach VV; Trotsenko OE; Davidovich MA
    Klin Lab Diagn; 1995; (4):38-9. PubMed ID: 7670820
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of anti-hepatitis C virus antibodies among patients with alcoholic liver disease, supplemented by 4-RIBA.
    Laurent-Puig P; Dussaix E; Lecoz Y; Martes P; Buffet C
    Dig Dis Sci; 1992 Jan; 37(1):156-7. PubMed ID: 1309449
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of ELISA cut-off reduces HCV-Ab false-positivity in patients with HBV, HDV and alcoholic liver disease.
    Andreone P; Cursaro C; Miniero R; Stefanini GF; Sprovieri G; Gasbarrini G
    Ital J Gastroenterol; 1991 Dec; 23(9):567-8. PubMed ID: 1662091
    [No Abstract]   [Full Text] [Related]  

  • 30. Sporadic vs. posttransfusion hepatitis C: why the differences?
    Achord JL
    Gastroenterology; 1991 Oct; 101(4):1133-4. PubMed ID: 1716237
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C virus testing of sera in Africa.
    Aceti A; Taliani G
    Trans R Soc Trop Med Hyg; 1992; 86(6):676. PubMed ID: 1337635
    [No Abstract]   [Full Text] [Related]  

  • 32. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease].
    Goeser T; Theilmann L
    Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: a seroepidemiological study.
    Gessoni G; Manoni F
    Eur J Med; 1993 Feb; 2(2):79-82. PubMed ID: 7504974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reactivity of hepatitis C virus (HCV) antibody among blood donors in Hungary].
    Héjjas M; Medgyesi G; Hajnal A
    Orv Hetil; 1992 Jul; 133 Suppl 1():21-4. PubMed ID: 1321394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability of immunoassays for anti-HCV antibodies (ELISA and RIBA II) in patients with essential mixed cryoglobulinemia (EMC).
    Monteverde A; Airoldi G; Ballarè M; Fortina G; Quaglia V; Pigatto A; Manzini P
    Clin Exp Rheumatol; 1993; 11(6):609-13. PubMed ID: 7507807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
    Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
    Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus and Sjögren's syndrome.
    Mariette X; Zerbib M; Jaccard A; Schenmetzler C; Danon F; Clauvel JP
    Arthritis Rheum; 1993 Feb; 36(2):280-1. PubMed ID: 8381650
    [No Abstract]   [Full Text] [Related]  

  • 40. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus.
    Bruno S; Rossi S; Petroni ML; Villa E; Zuin M; Podda M
    BMJ; 1994 Mar; 308(6930):697. PubMed ID: 8142795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.